The CircRNA CircSEPT9 Mediated by E2F1 and EIF4A3 Facilitates the Carcinogenesis and Development of Triple-negative Breast Cancer

Overview

Journal Mol Cancer

Publisher Biomed Central

Specialties Molecular Biology
Oncology

Date 2020 Apr 9

PMID 32264877

Citations 200

Authors

Xiaying Zheng

Mengge Huang

Lei Xing

Rui Yang

Xiaosong Wang

Rong Jiang

Luyu Zhang

Junxia Chen

Affiliations

Soon will be listed here.

Abstract

Background: Increasing studies have shown that circRNA is closely related to the carcinogenesis and development of many cancers. However, biological functions and the underlying molecular mechanism of circRNAs in triple-negative breast cancer (TNBC) remain largely unclear so far.

Methods: Here, we investigated the expression pattern of circRNAs in four pairs of TNBC tissues and paracancerous normal tissues using RNA-sequencing. The expression and prognostic significance of circSEPT9 were evaluated with qRT-PCR and in situ hybridization in two TNBC cohorts. The survival curves were drawn by the Kaplan-Meier method, and statistical significance was estimated with the log-rank test. A series of in vitro and in vivo functional experiments were executed to investigate the role of circSEPT9 in the carcinogenesis and development of TNBC. Mechanistically, we explored the potential regulatory effects of E2F1 and EIF4A3 on biogenesis of circSEPT9 with chromatin immunoprecipitation (ChIP), luciferase reporter and RNA immunoprecipitation (RIP) assays. Furthermore, fluorescent in situ hybridization (FISH), luciferase reporter and biotin-coupled RNA pull-down assays were implemented to verify the relationship between the circSEPT9 and miR-637 in TNBC.

Results: Increased expression of circSEPT9 was found in TNBC tissues, which was positively correlated with advanced clinical stage and poor prognosis. Knockdown of circSEPT9 significantly suppressed the proliferation, migration and invasion of TNBC cells, induced apoptosis and autophagy in TNBC cells as well as inhibited tumor growth and metastasis in vivo. Whereas up-regulation of circSEPT9 exerted opposite effects. Further mechanism research demonstrated that circSEPT9 could regulate the expression of Leukemia Inhibitory Factor (LIF) via sponging miR-637 and activate LIF/Stat3 signaling pathway involved in progression of TNBC. More importantly, we discovered that E2F1 and EIF4A3 might promote the biogenesis of circSEPT9.

Conclusions: Our data reveal that the circSEPT9 mediated by E2F1 and EIF4A3 facilitates the carcinogenesis and development of triple-negative breast cancer through circSEPT9/miR-637/LIF axis. Therefore, circSEPT9 could be used as a potential prognostic marker and therapeutical target for TNBC.

Citing Articles

MVGNCDA: Identifying Potential circRNA-Disease Associations Based on Multi-view Graph Convolutional Networks and Network Embeddings.

Sun G, Zheng M, Fan Y, Pan X Interdiscip Sci. 2025; .

PMID: 39962021 DOI: 10.1007/s12539-025-00690-x.

SPC25 upregulates CCND1 to promote the progression of esophageal squamous cell carcinoma by inhibiting MDM2-mediated E2F1 ubiquitination.

Jiang H, Jin X, Gu H, Li B, Li Z, Sun Y Transl Oncol. 2025; 53:102300.

PMID: 39919356 PMC: 11849203. DOI: 10.1016/j.tranon.2025.102300.

A novel peptide encoded by circSRCAP confers resistance to enzalutamide by inhibiting the ubiquitin-dependent degradation of AR-V7 in castration-resistant prostate cancer.

Meng X, Wu Q, Cao C, Yang W, Chu S, Guo H J Transl Med. 2025; 23(1):108.

PMID: 39844192 PMC: 11755828. DOI: 10.1186/s12967-025-06115-z.

Non-Coding RNAs in Breast Cancer: Diagnostic and Therapeutic Implications.

Benacka R, Szaboova D, Gulasova Z, Hertelyova Z Int J Mol Sci. 2025; 26(1.

PMID: 39795985 PMC: 11719911. DOI: 10.3390/ijms26010127.

The impact of ferroptosis and ferroptosis-related non-coding RNAs on breast cancer progression.

Liu W, Jiang C, Ma Y, Wang W, Peng J, Ma W Front Cell Dev Biol. 2025; 12:1506492.

PMID: 39763590 PMC: 11701165. DOI: 10.3389/fcell.2024.1506492.

References

Dong Y, He D, Peng Z, Peng W, Shi W, Wang J . Circular RNAs in cancer: an emerging key player. J Hematol Oncol. 2017; 10(1):2. PMC: 5210264. DOI: 10.1186/s13045-016-0370-2. View

Guestini F, McNamara K, Ishida T, Sasano H . Triple negative breast cancer chemosensitivity and chemoresistance: current advances in biomarkers indentification. Expert Opin Ther Targets. 2015; 20(6):705-20. DOI: 10.1517/14728222.2016.1125469. View

Zhen N, Gu S, Ma J, Zhu J, Yin M, Xu M . CircHMGCS1 Promotes Hepatoblastoma Cell Proliferation by Regulating the IGF Signaling Pathway and Glutaminolysis. Theranostics. 2019; 9(3):900-919. PMC: 6376477. DOI: 10.7150/thno.29515. View

Salmena L, Poliseno L, Tay Y, Kats L, Pandolfi P . A ceRNA hypothesis: the Rosetta Stone of a hidden RNA language?. Cell. 2011; 146(3):353-8. PMC: 3235919. DOI: 10.1016/j.cell.2011.07.014. View

Ng W, Mohidin T, Shukla K . Functional role of circular RNAs in cancer development and progression. RNA Biol. 2018; 15(8):995-1005. PMC: 6259826. DOI: 10.1080/15476286.2018.1486659. View

Cong Z, Diao Y, Xu Y, Li X, Jiang Z, Shao C . Long non-coding RNA linc00665 promotes lung adenocarcinoma progression and functions as ceRNA to regulate AKR1B10-ERK signaling by sponging miR-98. Cell Death Dis. 2019; 10(2):84. PMC: 6349882. DOI: 10.1038/s41419-019-1361-3. View

Zeng K, He B, Yang B, Xu T, Chen X, Xu M . The pro-metastasis effect of circANKS1B in breast cancer. Mol Cancer. 2018; 17(1):160. PMC: 6240936. DOI: 10.1186/s12943-018-0914-x. View

Fischer M, Grossmann P, Padi M, DeCaprio J . Integration of TP53, DREAM, MMB-FOXM1 and RB-E2F target gene analyses identifies cell cycle gene regulatory networks. Nucleic Acids Res. 2016; 44(13):6070-86. PMC: 4994865. DOI: 10.1093/nar/gkw523. View

Bach D, Lee S, Sood A . Circular RNAs in Cancer. Mol Ther Nucleic Acids. 2019; 16:118-129. PMC: 6411617. DOI: 10.1016/j.omtn.2019.02.005. View

10.

Xu J, Shao C, Wang X, Zhao X, Chen J, Ouyang Y . circTADA2As suppress breast cancer progression and metastasis via targeting miR-203a-3p/SOCS3 axis. Cell Death Dis. 2019; 10(3):175. PMC: 6382814. DOI: 10.1038/s41419-019-1382-y. View

11.

Yang R, Xing L, Zheng X, Sun Y, Wang X, Chen J . The circRNA circAGFG1 acts as a sponge of miR-195-5p to promote triple-negative breast cancer progression through regulating CCNE1 expression. Mol Cancer. 2019; 18(1):4. PMC: 6325825. DOI: 10.1186/s12943-018-0933-7. View

12.

Zhang J, He M, Fu W, Wang H, Chen L, Zhu X . Primate-specific microRNA-637 inhibits tumorigenesis in hepatocellular carcinoma by disrupting signal transducer and activator of transcription 3 signaling. Hepatology. 2011; 54(6):2137-48. DOI: 10.1002/hep.24595. View

13.

Zhang C, Wang G, Fu B, Zhou X, Li Y, Li Y . LncRNA CASC15 promotes migration and invasion in prostate cancer via targeting miR-200a-3p. Eur Rev Med Pharmacol Sci. 2019; 23(19):8303-8309. DOI: 10.26355/eurrev_201910_19141. View

14.

Hwang S, Park S, Kwon Y . Recent therapeutic trends and promising targets in triple negative breast cancer. Pharmacol Ther. 2019; 199:30-57. DOI: 10.1016/j.pharmthera.2019.02.006. View

15.

Meng J, Chen S, Han J, Qian B, Wang X, Zhong W . Twist1 Regulates Vimentin through Cul2 Circular RNA to Promote EMT in Hepatocellular Carcinoma. Cancer Res. 2018; 78(15):4150-4162. DOI: 10.1158/0008-5472.CAN-17-3009. View

16.

Gupta I, Sareyeldin R, Al-Hashimi I, Al-Thawadi H, Al Farsi H, Vranic S . Triple Negative Breast Cancer Profile, from Gene to microRNA, in Relation to Ethnicity. Cancers (Basel). 2019; 11(3). PMC: 6468678. DOI: 10.3390/cancers11030363. View

17.

Li Y, Zheng Q, Bao C, Li S, Guo W, Zhao J . Circular RNA is enriched and stable in exosomes: a promising biomarker for cancer diagnosis. Cell Res. 2015; 25(8):981-4. PMC: 4528056. DOI: 10.1038/cr.2015.82. View

18.

Leivonen S, Sahlberg K, Makela R, Due E, Kallioniemi O, Borresen-Dale A . High-throughput screens identify microRNAs essential for HER2 positive breast cancer cell growth. Mol Oncol. 2013; 8(1):93-104. PMC: 5528509. DOI: 10.1016/j.molonc.2013.10.001. View

19.

Li X, Wang Z, Ye C, Zhao B, Li Z, Yang Y . RNA sequencing reveals the expression profiles of circRNA and indicates that circDDX17 acts as a tumor suppressor in colorectal cancer. J Exp Clin Cancer Res. 2018; 37(1):325. PMC: 6307166. DOI: 10.1186/s13046-018-1006-x. View

20.

Chen X, Chen R, Wei W, Li Y, Feng Z, Tan L . PRMT5 Circular RNA Promotes Metastasis of Urothelial Carcinoma of the Bladder through Sponging miR-30c to Induce Epithelial-Mesenchymal Transition. Clin Cancer Res. 2018; 24(24):6319-6330. DOI: 10.1158/1078-0432.CCR-18-1270. View